A look at MHS's CARE-SALTOS update, its long-term research goals, and what the reported VA collaboration means for current care decisions.
On November 3, 2026, the Military Health System updated its brain-health research page. The page describes CARE-SALTOS as a Department of War and NCAA study tracking service-academy graduates and veterans over decades to look for early cognitive change and neurodegenerative conditions. Separately, it describes research collaboration with the VA intended to help clinicians distinguish chronic brain injury from other conditions.
The update highlights ongoing research rather than announcing completed long-term findings. Its practical importance lies in the questions being studied: how brain health changes after concussion or repetitive head impacts and how research can support care after military service.
The Military Health System describes a research agenda that extends beyond initial recovery. CARE-SALTOS includes neurological and psychological health alongside cognition and quality of life. Career or military performance is also part of the study’s stated objectives.
For active personnel, that makes performance part of the research question rather than a separate concern. For veterans, the focus on cognition and quality of life keeps the work relevant beyond duty status. The outcomes being studied concern both health and how people function over time.
The October report places this work within a progression from acute recovery to longer-term follow-up. That progression asks a broader question than how someone is doing soon after an injury. Researchers also want to understand health and performance after participants leave college and move into later stages of their lives.
For BattleVet, this connects with long-term military and veteran health, including recovery and healthy aging. The useful focus is on understanding the evidence well enough to support informed care decisions without turning a research objective into a personal forecast.
The Military Health System’s October 2026 report describes CARE-SALTOS as the long-term phase of the Department of War and NCAA research partnership. It follows former NCAA athletes and U.S. military service-academy participants after college to study concussion and repetitive head impacts.
The report describes the research phases this way:
These timeframes help explain the study’s direction. The partnership is moving from questions about recovery closer to an injury toward questions about outcomes later in participants’ lives.
According to the October report, the long-term objectives include assessing neurological and psychological health. Researchers also aim to assess cognition and quality of life alongside career or military performance.
The agenda includes studying brain structure and function through neuroimaging. It also includes examining markers associated with brain swelling and permanent brain damage. These measures sit alongside the health and functional outcomes rather than replacing them.
Another stated objective is developing a multilevel predictive algorithm to assess individual risk after head-impact exposure. The research question is whether the collected information can eventually support useful individual risk assessment.
Taken together, the objectives show why this is more than a symptom-tracking project. The research is intended to connect different kinds of measurements with outcomes that matter during service and afterward.
The Military Health System reported that a September 2026 conference brought together researchers and clinicians with military leaders and other stakeholders. Participants reviewed CARE-SALTOS progress and emerging findings while discussing potential practical applications.
The October report says the CARE Consortium’s preceding 12 years of research produced 176 peer-reviewed publications and approximately 190 scientific presentations. It also says the consortium dataset supported 14 additional projects.
Those figures describe the scale of the wider research effort. They provide context for the long-term phase and the scientific work supporting it.
The source descriptions differ in population and follow-up scope. The research page refers to service-academy graduates and veterans monitored over decades. The October report describes former NCAA athletes and service-academy participants and specifies evaluation up to 10 years after exposure. Those accounts should not be merged into a claim that all veterans have already been followed for decades.
The October report does not provide specific results from the planned long-term evaluation. The proposed risk algorithm is an objective rather than a completed or clinically validated tool. The publication and presentation totals describe a broad research record rather than proof that a particular diagnostic method or intervention works for an individual patient.
The VA-care statement also needs a narrow reading. The MHS research page says defense-research discoveries are integrated into VA Polytrauma Centers. It does not identify specific studies or explain which findings and tools are being used at particular centers. The separate CARE-SALTOS report does not describe that integration.
These distinctions separate three stages that matter in health reporting: a research goal, a reported finding and a demonstrated clinical application. The current update contains important goals and descriptions of collaboration, but those stages are not interchangeable.
For current health decisions, the clearest implications concern how symptoms are discussed and how care is coordinated. The update reinforces careful assessment through qualified care rather than offering a new way to diagnose a condition independently.
The MHS says its VA collaboration is working to distinguish chronic brain injury from PTSD, anxiety, and sleep disorders. The practical takeaway is to describe symptoms and relevant injury history to a qualified clinician rather than assume a symptom has a single cause.
That distinction matters when interpreting this update. The subject is how clinicians may better assess different explanations for a person’s concerns. It is not a reason to assign every concern to an earlier injury or to dismiss injury history before an evaluation.
Individual diagnostic and treatment decisions belong with qualified care. The useful contribution from this research summary is context for that conversation, not a conclusion about any reader’s condition.
Neuroimaging and biological markers are part of the stated research agenda. Their inclusion shows what researchers intend to examine, not which test an individual reader should receive.
In practice, a research team asking which measures might predict future outcomes is addressing a different question from a clinician evaluating someone’s current concerns. The appropriate discussion in care is how a proposed assessment would help address those concerns.
This keeps testing decisions tied to the clinical question. It also avoids treating the presence of a technology in a research program as a recommendation for routine use.
The MHS research page points service members and families toward recovery guidance and health resources. It also describes return-to-learn and return-to-duty steps as part of its brain-health resources.
The page does not provide enough detail to reproduce those protocols here. Return-to-duty and related performance decisions should remain with the military healthcare team and relevant official guidance rather than be drawn from this summary.
For veterans, the practical emphasis is continuity of care. Current symptoms and relevant injury history belong in an ongoing clinical conversation. BattleVet’s guide to organizing healthcare after service provides broader context for building that care relationship.
The central guidance is straightforward: use the update to understand the research direction while keeping personal decisions grounded in qualified assessment.
The next useful milestone would be reporting that connects specific long-term findings with specific clinical decisions. That would make it easier to understand how research measurements relate to the health and functional outcomes CARE-SALTOS is studying.
For the reported VA partnership, useful future detail would include which findings are entering care and how their value is assessed. Clear reporting on that translation would help distinguish scientific progress from changes that directly affect an appointment or care plan.
The study’s stated outcomes provide a practical standard for judging that progress: neurological and psychological health alongside cognition and quality of life. Career or military performance remains part of that picture as well.
As CARE-SALTOS develops its longer-term evidence, how will military and VA healthcare show that those findings improve diagnostic decisions and everyday outcomes for veterans?
Follow BattleVet for practical guidance on military and veteran health, strength, recovery, testosterone, sleep and healthy aging. Stay connected for new articles, research backed insights and clear information to help you stay capable for the years ahead.
A 14-study review highlights fatigue and distress in military drone crews, with implications for sleep, schedules and occupational-health support.
VA highlights links between blast exposure and later diagnoses. Review the findings, evidence limits and implications for veteran health follow-up.
NPR found higher payments in thousands of VA loan modifications. Understand the VASP transition, replacement program, and implications for veteran health.
Build better habits around strength, recovery, sleep, hormones and healthy aging with practical guidance for active military personnel and veterans.
Explore BattleVet